420 related articles for article (PubMed ID: 29376496)
1. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
2. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
3. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
4. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
[TBL] [Abstract][Full Text] [Related]
5. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
[TBL] [Abstract][Full Text] [Related]
6. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.
Morelli S; Reboldi G; Moretti S; Menicali E; Avenia N; Puxeddu E
Endocrine; 2016 Jun; 52(3):571-8. PubMed ID: 26537478
[TBL] [Abstract][Full Text] [Related]
7. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
8. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
9. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
10. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
11. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
12. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
[TBL] [Abstract][Full Text] [Related]
14. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
15. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
[TBL] [Abstract][Full Text] [Related]
17. Long term therapy with a new liquid L-thyroxine preparation: bioequivalence with L-T4 tablets.
Carpi A; Toni MG; Maccheroni M; De Gaudio C
Thyroidology; 1992 Dec; 4(3):115-9. PubMed ID: 1285037
[TBL] [Abstract][Full Text] [Related]
18. Oral liquid levothyroxine treatment at breakfast: a mistake?
Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
[TBL] [Abstract][Full Text] [Related]
19. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study.
Ernst FR; Sandulli W; Elmor R; Welstead J; Sterman AB; Lavan M
Drugs R D; 2017 Mar; 17(1):103-115. PubMed ID: 27943146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
